Monitoring Services

CMX has also monitored over 75 Bioavailability/Bioequivalent (BA/BE) studies for multiple pharmaceutical companies across the globe.

Monitoring is conducted effectively and efficiently by trained and certified Clinical Research Associates (CRAs). Our services include Site Qualification Visits (SQVs), Site Initiation Visits (SIVs), Interim Monitoring Visits (IMVs), and Close-Out Visits (COVs) and are coordinated according to the sponsor’s requirements or monitoring plan.

CMX monitors any medical indication and all phases I-IV including; Urology, Oncology, Immunology, Cardiology, Dermatology, Endocrinology, Respirology, and Medical Devices.

All studies will be monitored for compliance to ICH GCP. A regulatory overview includes reviewing the Site Master File (SMF) and the essential documents to ensure data integrity.